- LYN-1604
-
- $106.00 / 1mg
-
2024-11-19
- CAS:2088939-99-3
- Min. Order:
- Purity:
- Supply Ability: 10g
- LYN-1604
-
- $1.00 / 1KG
-
2024-10-22
- CAS:2088939-99-3
- Min. Order: 1KG
- Purity: MIn98%HPLC/LC
- Supply Ability: 100KGS
|
| LYN-1604 Basic information |
Product Name: | LYN-1604 | Synonyms: | LYN-1604;LYN-1604 Hcl;CS-2610;CS-2635;LYN-1604;LYN 1604;LYN1604;LYN1604;LYN 1604;Ethanone, 2-[bis(2-methylpropyl)amino]-1-[4-[2-(2,4-dichlorophenyl)-2-(2-naphthalenylmethoxy)ethyl]-1-piperazinyl]-;LYN-1604 2HCl | CAS: | 2088939-99-3 | MF: | C33H43Cl2N3O2 | MW: | 584.62 | EINECS: | | Product Categories: | | Mol File: | 2088939-99-3.mol | |
| LYN-1604 Chemical Properties |
Boiling point | 670.9±55.0 °C(Predicted) | density | 1.168±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMF: 30 mg/ml; DMSO: 20 mg/ml; Ethanol: 30 mg/ml; Ethanol:PBS(pH 7.2) (1:1): 0.5 mg/ml | form | A crystalline solid | pka | 8.03±0.50(Predicted) |
| LYN-1604 Usage And Synthesis |
Description | LYN-1604 is an activator of unc-51-like kinase 1 (ULK1; EC50 = 18.94 nM). It increases Beclin 1, LC3-II, and total LC3 protein levels and reduces levels of p62 in human MDA-MB-231 triple-negative breast cancer (TNBC) cells in a concentration-dependent manner, indicating an increase in autophagy. It also increases the cleavage of the pro-apoptotic protein caspase-3. LYN-1604 decreases the viability of MDA-MB-231 cells in vitro (IC50 = 1.66 μM), an effect that can be reversed by the autophagy inhibitor 3-methyladenine (3-MA; ). LYN-1604 (25, 50, and 100 mg/kg) reduces tumor growth in an MDA-MB-231 mouse xenograft model. |
| LYN-1604 Preparation Products And Raw materials |
|